OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genome-Scale Networks Link Neurodegenerative Disease Genes to α-Synuclein through Specific Molecular Pathways
Vikram Khurana, Jian Peng, Chee Yeun Chung, et al.
Cell Systems (2017) Vol. 4, Iss. 2, pp. 157-170.e14
Open Access | Times Cited: 108

Showing 26-50 of 108 citing articles:

Specification of Physiologic and Disease States by Distinct Proteins and Protein Conformations
Daniel F. Jarosz, Vikram Khurana
Cell (2017) Vol. 171, Iss. 5, pp. 1001-1014
Open Access | Times Cited: 41

Potentiating Hsp104 activity via phosphomimetic mutations in the middle domain
Amber Tariq, JiaBei Lin, Megan M. Noll, et al.
FEMS Yeast Research (2018) Vol. 18, Iss. 5
Open Access | Times Cited: 41

Using Patient-Derived Induced Pluripotent Stem Cells to Identify Parkinson’s Disease-Relevant Phenotypes
Samantha L. Sison, Scott Vermilyea, Marina E. Emborg, et al.
Current Neurology and Neuroscience Reports (2018) Vol. 18, Iss. 12
Open Access | Times Cited: 41

Glial α‐synuclein promotes neurodegeneration characterized by a distinct transcriptional program in vivo
Abby L. Olsen, Mel Β. Feany
Glia (2019) Vol. 67, Iss. 10, pp. 1933-1957
Open Access | Times Cited: 37

Organoid and pluripotent stem cells in Parkinson’s disease modeling: an expert view on their value to drug discovery
Nicolas Marotta, Soojin Kim, Dimitri Krainc
Expert Opinion on Drug Discovery (2020) Vol. 15, Iss. 4, pp. 427-441
Open Access | Times Cited: 33

Precision medicine — networks to the rescue
Anupama Yadav, Marc Vidal, Katja Luck
Current Opinion in Biotechnology (2020) Vol. 63, pp. 177-189
Open Access | Times Cited: 33

Selectivity of Lewy body protein interactions along the aggregation pathway of α-synuclein
André Leitão, Paulina Soto, Alexandre Chappard, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 32

Modelling Parkinson’s Disease: iPSCs towards Better Understanding of Human Pathology
Sahar Avazzadeh, Jara M. Baena-Montes, Cameron Noah Keighron, et al.
Brain Sciences (2021) Vol. 11, Iss. 3, pp. 373-373
Open Access | Times Cited: 31

Randomized CRISPR-Cas Transcriptional Perturbation Screening Reveals Protective Genes against Alpha-Synuclein Toxicity
Ying‐Chou Chen, Fahim Farzadfard, Nava Gharaei, et al.
Molecular Cell (2017) Vol. 68, Iss. 1, pp. 247-257.e5
Open Access | Times Cited: 34

Disposable Morpho menelaus Based Flexible Microfluidic and Electronic Sensor for the Diagnosis of Neurodegenerative Disease
Zhenzhu He, Abdelrahman Elbaz, Bingbing Gao, et al.
Advanced Healthcare Materials (2018) Vol. 7, Iss. 5
Closed Access | Times Cited: 34

Rapid Alpha-Synuclein Toxicity in a Neural Cell Model and Its Rescue by a Stearoyl-CoA Desaturase Inhibitor
Elizabeth Terry-Kantor, Arati Tripathi, Thibaut Imberdis, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5193-5193
Open Access | Times Cited: 29

Upregulation of Cellular Palmitoylation Mitigates α‐Synuclein Accumulation and Neurotoxicity
Gary P. H. Ho, Nagendran Ramalingam, Thibaut Imberdis, et al.
Movement Disorders (2020) Vol. 36, Iss. 2, pp. 348-359
Open Access | Times Cited: 29

Sequence-based prediction of protein-protein interactions: a structure-aware interpretable deep learning model
Samuel Sledzieski, Rohit Singh, Lenore Cowen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 27

Roles for α-Synuclein in Gene Expression
Mahalakshmi Somayaji, Zina Lanseur, Se Joon Choi, et al.
Genes (2021) Vol. 12, Iss. 8, pp. 1166-1166
Open Access | Times Cited: 25

Therapeutic strategies for targeting neurodegenerative protein misfolding disorders
Robert H. Scannevin
Current Opinion in Chemical Biology (2018) Vol. 44, pp. 66-74
Closed Access | Times Cited: 31

Functional protein representations from biological networks enable diverse cross-species inference
Jason Fan, Anthony F. Cannistra, Inbar Fried, et al.
Nucleic Acids Research (2019) Vol. 47, Iss. 9, pp. e51-e51
Open Access | Times Cited: 26

Therapeutic genetic variation revealed in diverse Hsp104 homologs
Zachary M. March, Katelyn Sweeney, Hanna Kim, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 26

DEAD-box RNA helicase Dbp4/DDX10 is an enhancer of α-synuclein toxicity and oligomerization
Bilyana Popova, Dan Wang, Christina Pätz, et al.
PLoS Genetics (2021) Vol. 17, Iss. 3, pp. e1009407-e1009407
Open Access | Times Cited: 22

Parkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection
Sheila K. Pirooznia, Liana S. Rosenthal, Valina L. Dawson, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 4, pp. 1204-1268
Open Access | Times Cited: 21

Progress toward an integrated understanding of Parkinson’s disease
Maxime W.C. Rousseaux, Joshua Shulman, Joseph Jankovic
F1000Research (2017) Vol. 6, pp. 1121-1121
Open Access | Times Cited: 28

Scroll to top